LIQUID BIOPSY

This study tests whether a urine DNA test can help doctors decide how long to give immunotherapy for a severe type of bladder cancer that can't be fully removed with surgery. About 53 adults with very-high-risk non-muscle-invasive bladder cancer will receive immunotherapy, and th…

This study tests whether a simple blood and urine test (liquid biopsy) can help diagnose, monitor treatment response, and predict recurrence in people with urothelial carcinoma (a type of bladder cancer). Researchers will compare these non-invasive tests to standard tissue biopsi…

This study looks at whether a urine test that detects tumor DNA and RNA can help doctors decide which high-risk bladder cancer patients truly need a second surgery. Currently, many patients undergo a repeat procedure, but it may not always be necessary. The goal is to see if the …

This study aims to develop a blood test that uses genetic material from tiny particles (exosomes) to predict whether prostate cancer has spread to the bones. Researchers will analyze blood samples from 1,000 men with newly diagnosed prostate cancer and compare the results to PSMA…

This study is for people with high-risk bladder cancer who need regular check-ups with a camera in the bladder (cystoscopy). The camera test is uncomfortable and can cause side effects. Researchers want to see if a non-invasive urine test that looks for cancer DNA can help decide…

This study looks at whether a simple urine test that detects tumor DNA can identify bladder cancer patients who truly need a second surgery. About 196 adults with early-stage bladder cancer will be randomly assigned to have their repeat surgery decision guided by the urine test o…